Skip to content

Reduction in Sedation: Colonoscopy vs Esophagoduodenoscopy First

RECoVER: Reduction in Sedation: Colonoscopy vs Esophagoduodenoscopy First

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04096339
Acronym
RECoVER
Enrollment
120
Registered
2019-09-19
Start date
2019-07-03
Completion date
2020-01-30
Last updated
2019-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Recovery

Keywords

Colonoscopy, EGD, Sedation, procedural sequence

Brief summary

The purpose of this research is to compare the effect of different procedural sequences on the time to recovery and the propofol sedation requirements in patients undergoing bidirectional endoscopy with sedation. The two sequences are: * Colonoscopy followed by Esophagogastroduodenoscopy (EGD) * EGD followed by Colonoscopy

Detailed description

120 patients will be asked to participate in the trial. The subject will undergo both procedures in the order assigned by the randomization sheet. During the procedure, the endoscopist and anesthesiologists will collect data including but not limited to vital signs (heart rate, blood oxygen level, blood pressure) and level of sedation through the Bispectral Index Monitor (BIS). After completing the procedures, the patient will be approached in the recovery room by the study coordinator who will administer the Modified Post Anesthesia Discharge Scoring System (M-PADSS) scale every 5 minutes until a score of 9 or higher is obtained on two consecutive attempts. 24 hours following the procedure, the study coordinator will call the patient in order to assess the patient's cognitive function and drowsiness after they were discharged from the endoscopy unit.

Interventions

OTHERColonoscopy followed by EGD

Colonoscopy is done first followed by EGD

OTHEREGD followed by Colonoscopy

Esophagoduodenoscopy (EGD) is done first followed by Colonoscopy

Sponsors

American University of Beirut Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age above 18 * Scheduled EGD and colonoscopy on the same day * Scheduled to Anaesthesiologist administered sedation during the procedure

Exclusion criteria

* Age below 18 * Known allergy or adverse reaction to Propofol, Midazolam or opioid medication (ex: fentanyl) * Medical contraindication to Anaesthesia * Sleep apnea * American Society of Anesthesiologists classification (ASA) \>3 * Inpatient status * Pregnant or lactating women * Known cirrhosis * Chronic Kidney Disease (stage 4 or 5) * Known psychological disorder * Known cognitive dysfunction * Significant gastroparesis * Gastric outlet obstruction * Ileus * Known or suspected bowel obstruction or perforation * Having a stoma * Compromised swallowing reflex or mental status * Prior colon resection or gastric surgery * Age above 75 years * Chronic use of more than 1 psychoactive drug (Benzodiazepines, Tricyclic antidepressants, antipsychotics, selective serotonin receptor inhibitors, serotonin norepinephrine receptor inhibitors, Monoamine oxidase inhibitor)

Design outcomes

Primary

MeasureTime frameDescription
Time to discharge1 hourTime from end of procedures to patient discharge

Secondary

MeasureTime frameDescription
Propofol dose1 hourPropofol sedation requirements
Depth of anesthesia1 hourBispectral Index (BIS) tracking of depth of anesthesia throughout the two procedures. BIS is a single dimensionless number generated by EEG analysis.
Cognitive impairment24 hoursAn assessment of cognitive impairment after the subject emerges from sedation, using the Modified Post Anesthesia Discharge System (M-PADS)
Adverse events during sedation1 hourapnea, desaturations, hypotension, bradycardia and other hemodynamical disturbances during sedation

Countries

Lebanon

Contacts

Primary ContactAla I Sharara, MD
as08@aub.edu.lb+961-1-350000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026